Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study | Zendy

Bérengère Koehl | Zendy; Camille Aupiais | Zendy; Nelly Schinckel | Zendy; Pierre Mornand | Zendy; MarieHélène Odièvre | Zendy; Assa Niakaté | Zendy; Valentine Brousse | Zendy; Ghislaine Ithier | Zendy; Florence Missud | Zendy; Laurent Holvoet | Zendy; Malika Benkerrou | Zendy; F. Sorge | Zendy; Albert Faye | Zendy

Open Access

Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study

Author(s) -

Bérengère Koehl,

Camille Aupiais,

Nelly Schinckel,

Pierre Mornand,

MarieHélène Odièvre,

Assa Niakaté,

Valentine Brousse,

Ghislaine Ithier,

Florence Missud,

Laurent Holvoet,

Malika Benkerrou,

F. Sorge,

Albert Faye

Publication year - 2021

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.1093/jtm/taab013

Subject(s) - medicine , vaccination , immunogenicity , adverse effect , yellow fever vaccine , immune system , antibody , immunology , yellow fever , virus

Sickle cell disease (SCD) children are frequent travellers to countries where yellow fever (YF) is endemic, but there are no data regarding the safety and immunogenicity of the vaccine in such children treated with hydroxyurea (HU). The main objective of this study was to compare the tolerance and immune response to YF vaccination in SCD children treated or not with HU.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research